Phase II Trial of High-Dose Rituximab with High-dose Cytarabine Mobilization Therapy and High-Dose Thiotepa, Busulfan, and Cyclophosphamide (R-TBC) Autologous Stem Cell Transplant in Patients with CNS Involvement by Non-Hodgkin Lymphoma

BACKGROUND: High-dose thiotepa, busulfan, and cyclophosphamide (TBC) with autologous stem cell transplantation (ASCT) has been used in patients with central nervous system (CNS) involvement by non-Hodgkin lymphoma (NHL). Despite limited penetration into the CNS, rituximab (R) is active in primary CN...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer
Autori principali: Chen, Yi-Bin, Batchelor, Tracy, Li, Shuli, Hochberg, Ephraim, Brezina, Mark, Jones, Sooae, Del Rio, Candice, Curtis, Morgan, Ballen, Karen K., Barnes, Jeffrey, Chi, Andrew S., Dietrich, Jorg, Driscoll, Jessica, Gertsner, Elizabeth R., Hochberg, Fred, LaCasce, Ann S., McAfee, Steven L., Spitzer, Thomas R., Nayak, Lakshmi, Armand, Philippe
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4293259/
https://ncbi.nlm.nih.gov/pubmed/25204639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.29023
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi